NEW YORK, April 28 -- Nature Cancer, a journal that says it focuses on cancer biology and genetics, approaches for the development and delivery of diagnostics and therapies, ways of understanding the global societal impact of cancer, published research articles on the following topics in its April 2023 edition:

Research:

* Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor toxicity for immunotherapy in solid tumors

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products